ArticleMolecular therapy oncolytics2023
esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation.
Jessica Swanner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it